[go: up one dir, main page]

WO2002000884A3 - Nucleotide sequence of influenza a/udorn/72 (h3n2) genome - Google Patents

Nucleotide sequence of influenza a/udorn/72 (h3n2) genome Download PDF

Info

Publication number
WO2002000884A3
WO2002000884A3 PCT/US2001/019826 US0119826W WO0200884A3 WO 2002000884 A3 WO2002000884 A3 WO 2002000884A3 US 0119826 W US0119826 W US 0119826W WO 0200884 A3 WO0200884 A3 WO 0200884A3
Authority
WO
WIPO (PCT)
Prior art keywords
influenza
udorn
genome
nucleotide sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/019826
Other languages
French (fr)
Other versions
WO2002000884A2 (en
Inventor
Jose M Galarza
Theresa E Latham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to BR0111819-6A priority Critical patent/BR0111819A/en
Priority to IL15300501A priority patent/IL153005A0/en
Priority to AU2001270033A priority patent/AU2001270033A1/en
Priority to MXPA02012255A priority patent/MXPA02012255A/en
Priority to CA002410284A priority patent/CA2410284A1/en
Priority to EP01948565A priority patent/EP1292614A2/en
Priority to JP2002506199A priority patent/JP2004514415A/en
Publication of WO2002000884A2 publication Critical patent/WO2002000884A2/en
Publication of WO2002000884A3 publication Critical patent/WO2002000884A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The complete nucleotide sequence of each of the eight segments of the negative strand Influenza A virus strain A/Udorn/72 (H3N2) is disclosed, which provides the complete sequence of the genome in antigenomic message sense. The sequence is useful in diagnosis and may be modified by mutation to generate new influenza A variant strains.
PCT/US2001/019826 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome Ceased WO2002000884A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
BR0111819-6A BR0111819A (en) 2000-06-23 2001-06-21 Isolated nucleic acid molecules, and isolated amino acid sequence
IL15300501A IL153005A0 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
AU2001270033A AU2001270033A1 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza A/Udorn/72 (H3N2) genome
MXPA02012255A MXPA02012255A (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome.
CA002410284A CA2410284A1 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
EP01948565A EP1292614A2 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
JP2002506199A JP2004514415A (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza A / Udorn / 72 (H3N2) genome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21365000P 2000-06-23 2000-06-23
US60/213,650 2000-06-23

Publications (2)

Publication Number Publication Date
WO2002000884A2 WO2002000884A2 (en) 2002-01-03
WO2002000884A3 true WO2002000884A3 (en) 2002-08-15

Family

ID=22795944

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019826 Ceased WO2002000884A2 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome

Country Status (10)

Country Link
EP (1) EP1292614A2 (en)
JP (1) JP2004514415A (en)
KR (1) KR20030013451A (en)
CN (1) CN1437612A (en)
AU (1) AU2001270033A1 (en)
BR (1) BR0111819A (en)
CA (1) CA2410284A1 (en)
IL (1) IL153005A0 (en)
MX (1) MXPA02012255A (en)
WO (1) WO2002000884A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160759A1 (en) * 2002-09-28 2006-07-20 Jianzhu Chen Influenza therapeutic
US8288523B2 (en) 2003-09-11 2012-10-16 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
PT1831357E (en) * 2004-12-24 2012-12-17 Univ Erasmus Medical Ct Rescue of influenza virus
CN103451158B (en) * 2005-04-21 2018-11-23 佛罗里达大学研究基金公司 The substance and method controlled for respiratory disease in canid
EP1877418B1 (en) 2005-05-06 2013-11-20 Gen-Probe Incorporated Compositions and assays to detect influenza virus a nucleic acids
US20100190842A1 (en) * 2007-04-12 2010-07-29 Alnylam Pharmaceuticals, Inc. Influenza polynucleotides, expression constructs, compositions, and methods of use
KR100913425B1 (en) 2007-05-14 2009-08-21 녹십자수의약품(주) Influenza Virus and Immunogenic Compositions Comprising the Same
CA2745532A1 (en) * 2008-12-19 2010-06-24 Denis Bouvier Polypeptide fragments comprising endonuclease activity and their use
WO2012009373A2 (en) 2010-07-12 2012-01-19 Gen-Probe Incorporated Compositions and assays to detect swine h1n1 influenza a virus, seasonal h1 influenza a virus and seasonal h3 influenza a virus nucleic acids
CN107488743A (en) * 2017-08-30 2017-12-19 上海伯杰医疗科技有限公司 H3N2 subtype influenza virus genome sequencing methods

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BISHOP D.H.L. ET AL.: "The complete sequence of RNA segment 2 of influenza A/NT/60/68 and its encoded P1 protein", NUCL. ACIDS RES., vol. 10, no. 4, 1982, pages 1335 - 1343, XP008003848 *
DE LA LUNA S. ET AL.: "Molecular cloning and sequencing of influenza virus A/VICTORIA/3/75 polymerase genes: sequence evolution and prediction of possible functional domains.", VIRUS RES., vol. 13, no. 2, 1989, pages 143 - 155, XP008003846 *
IUFEROV V.P. ET AL.: "[Nucleotide sequence of the hemagglutinin gene of the influenza virus A/UDORN/307/72 (H3N2)] (in Russian)", DOKLADY AKADEMII NAUK SSSR, vol. 278, no. 3, 1984, pages 738 - 742, XP008003843 *
LAWSON C.M. ET AL.: "Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus.", VIROLOGY, vol. 191, 1992, pages 506 - 510, XP002200635 *
MARKOFF L. & LAI C.J.: "Sequence of the influenza A/UDORN/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA.", VIROLOGY, vol. 119, no. 2, 1982, pages 288 - 297, XP008003845 *
OKAZAKI K. ET AL.: "Evolutionary pathways of the PA gnes of influenza viruses", VIROLOGY, vol. 172, no. 2, 1989, pages 601 - 608, XP008003844 *
PETROV N.A. ET AL.: "[Primary structure of the full-size DNA copy of the influenza virus A/KIEV/59/79 PB1 gene protein] (in Russian)", BIOORGANICESKAYA KHIMIYA, vol. 13, no. 9, 1987 - 2002, pages 1170 - 1175, XP008003847 *

Also Published As

Publication number Publication date
IL153005A0 (en) 2003-06-24
JP2004514415A (en) 2004-05-20
KR20030013451A (en) 2003-02-14
WO2002000884A2 (en) 2002-01-03
BR0111819A (en) 2004-01-06
AU2001270033A1 (en) 2002-01-08
CA2410284A1 (en) 2002-01-03
CN1437612A (en) 2003-08-20
EP1292614A2 (en) 2003-03-19
MXPA02012255A (en) 2003-04-25

Similar Documents

Publication Publication Date Title
WO2002000884A3 (en) Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
ES2526191T3 (en) Method to produce infectious influenza B virus in cell culture
JP2004509903A5 (en)
LU91367I2 (en) A complete inactivated influenza virus vaccine prepared from a germ strain produced by using reverse genetics and optionally including an adjuvant
NZ597601A (en) Treatment and prevention of influenza
CA2154023A1 (en) Recombinant infectious non-segmented negative strand rna virus
DE69832624D1 (en) HEFESTAMMS FOR THE PREPARATION OF MILKY ACID
BRPI0518568A2 (en) Method for producing a replicative influenza virus particle without the use of helper virus, replicative influenza virus particle, Cell, composition, use of a composition, Method for generating immunological protection against infection of an individual with an influenza virus, , Nucleic acid
EP1375652A3 (en) Oral compositions for HIV-Infected Subjects
EP2316923A3 (en) Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
AR069653A2 (en) ASPERGILLUS ORIGINAL GLUCOAMYLASE VARIANTE, A DNA CONSTRUCTION, A RECOMBINANT EXPRESSION VECTOR, A CELL, A PROCESS TO CONVERT ALMIDON, USE OF A GLUCOAMYLASE VARIANTE FOR A FERMENTATION AND METHOD PROCESS TO ALTER THE TERMINATION.
WO2004094466A3 (en) Recombinant influenza viruses holding a mutation in a transmembrane protein gene
BR9904747A (en) Microorganism, and, process to produce l-glutamic acid
BR9904449A (en) Process for the preparation of pantothenic acid through amplification of nucleotide sequences, which encode ketopantoate reductase
ATE553191T1 (en) CODONE-OPTIMIZED ALKALINE PHOSPHATASE AND ITS EXPRESSION IN YEAST
WO2002026979A1 (en) NOVEL ENZYME HAVING β-GLUCOSIDASE ACTIVITY AND USE THEREOF
EP1710300A4 (en) HIGHLY VARIATED VACCINE VIRUS AND VACCINE VIRUS VECTOR
WO1999004011A3 (en) Hiv-1 group o antigens and uses thereof
GB0020331D0 (en) Enzyme
Schlesinger et al. Mechanisms involved in natural and experimental neuropathogenicity of influenza viruses: evidence and speculation
BR0001342A (en) Process for the production of l-amino acids by fermentation using corineform bacteria
HUP0303878A2 (en) Smallpox vaccine
DE60231821D1 (en) RECOMBINANT TOLLWOOD VACCINES AND METHOD FOR THEIR PREPARATION AND USE
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
WO2006060257A3 (en) Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2410284

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 153005

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001948565

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/012255

Country of ref document: MX

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 506199

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001270033

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020027017495

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 018116493

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020027017495

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001948565

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: 2001948565

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001948565

Country of ref document: EP